Viewing Study NCT05353205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-06-13 @ 8:30 PM
Study NCT ID: NCT05353205
Status: UNKNOWN
Last Update Posted: 2022-04-29
First Post: 2022-04-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CML, Chronic Phase View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CML, Chronic Phase View
None Flumatinib View
None BCR-ABL TKI View
None Dose-optimization View
None Double-blind View
None Phase 4 View